# Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)

> **NCT06353334** · PHASE4 · RECRUITING · sponsor: **Tang Ziren** · enrollment: 100 (estimated)

## Conditions studied

- Butylphthalide
- Cardiac Arrest
- Neuroprotective Drugs

## Interventions

- **DRUG:** Butylphthalide and Sodium Chloride Injection
- **DRUG:** Saline Solution

## Key facts

- **NCT ID:** NCT06353334
- **Lead sponsor:** Tang Ziren
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06353334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06353334, "Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06353334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*